ONWARD® to Participate in Degroof Petercam Healthcare
CEO Dave Marver will provide update on the Company’s progress toward launch of its first therapy later this year...
Stay updated with breaking news from Breakthrough Device Designations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CEO Dave Marver will provide update on the Company’s progress toward launch of its first therapy later this year...
HemON NL is evaluating the use of ARC-IM® Therapy to address hemodynamic instability after spinal cord injury EINDHOVEN, the Netherlands, Jan. 18, 2024 -- ONWARD Medical N.V. , the medical...
The global in vitro diagnostics market is expanding rapidly due to a surge in the number of diagnostic laboratories, rise in awareness regarding personalized medicine and early disease diagnosis, and growing prevalence of infectious and chronic diseases.Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "In Vitro Diagnostics Market by Product and Services (Reagents and Kits, Instruments, Software, and Services), Technique, (Immunodiagnostic
Therapy to be supported by newly awarded $1M grant from Michael J. Fox FoundationEINDHOVEN, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a publication in Nature Medicine using investigational ONWARD ARC Therapy to address gait challenges related to Parkinson’s disea
EINDHOVEN, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function,